<!--START from /var/www/html/php4/ydp_trunk/local/templates/ydpprotocol/protocol_form_template.html comment made with MMCM-->
{clni_form}
<h3>Coronary Artery Disease</h3>
1. Key elements of the history/physical that are treatment targets for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="history_targets" type="text" size="50"
value="Years of known coronary artery disease, complications (CHF), treatment history, smoking history, obesity
"}<br>

2. What are the patients Risk Factors that are treatment targets for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="risk_factors" type="text" size="50" 
value="Family history, obesity, hypertension, lipid elevation, protocols not indicated or contraindicated, patient declined, economic, social, religious, resource unavailable, insurance limitations, other
"}<br>

3. What are the Treatment Goals for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="treatment_goals" type="text" size="50" 
value="Compliance with medications and other treatment, regular exercise, diet with antioxidants.
"}<br>

4. What are the typical Medications for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="medications" type="text" size="50" 
value="Anti-platelet: Aspirin,
Beta blockers if prior MI
ACE inhibitor if diabetes or left ventricular systolic dysfunction
Lipid medication if elevated 

"}<br>

5. Indications for lab studies for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="lab_studies" type="text" size="50" 
value="Complete blood count, urinalysis, serum electrolytes (including calcium and magnesium), blood urea nitrogen, serum creatinine, fasting blood glucose, lipid profile, liver function tests, and thyroid-stimulating hormone, Screening for hemochromatosis, sleep-disturbed breathing, or human immunodeficiency virus, in selected patients, rheumatologic diseases, amyloidosis, or pheochromocytoma, if indicated, Endomyocardial biopsy, when specific diagnosis is suspected that would influence therapy

"}<br>

6. Indications for imaging studies for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="imaging_studies" type="text" size="50" 
value="Baseline EKG, CXR- PA/ Lateral, Two-dimensional echocardiogram coupled with Doppler flow studies,  Coronary arteriography in appropriate patients, Maximal exercise testing with or without measurement of respiratory gas exchange and/or blood oxygen saturation in appropriate patients, Holter monitoring, if indicated

"}<br>

7. Outcome goals for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="followup" type="text" size="50"
value="Key indicators 
Percentage of patients with CAD prescribed antiplatelet therapy
Percentage of patients with CAD prescribed lipid lowering therapy per guideline
Percentage of patients with prior MI prescribed beta blocker
Percentage of patients with blood pressure measurement in last office visit
Percentage of patients receiving at least one lipid profile during the reporting year
Percentage of patients with most recentl LDL cholesterol < 130 mg/dl
Percentage of patients with CAD who have DM / LVSD and are prescribed ACEI
YDP additional standards
Patient understanding of disease, satisfaction with care
Percentage goals met per risk factor adjusted diagnosis
Percentage of patients weight weighed and counselled on weight, exercise

"}<br>

8. Referral criteria, if referring patient out for Coronary Artery Disease?<br>
{input style="width: 6in; height: 1in;" name="followup" type="text" size="50"
value="Nutrition: New onset diabetes, BMI > 25
Hypertension: Maximize treatment and not to goal
Cardiology: Unstable angina

"}<br>

<input type='hidden' name='force_new_version' value='true'>

<input type='hidden' name="external_id" value="{$user_id}" id="external_id">
{submit}
</form>
<!--END from /var/www/html/php4/ydp_trunk/local/templates/ydpprotocol/protocol_form_template.html comment made with MMCM-->